Publications and health information

Baeten JM, Donnell D, Kapiga SH, Ronald A, John-Stewart G, Inambao M, Manongi R, Vwalika B, Celum C, for the Partners in Prevention HSV/HIV Transmission Study Team. Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples. AIDS. 2010 March 13; 24(5):737-44.

Boltz VF, Maldarelli F, Martinson N, Morris L, McIntyre JA, Gray G, Hopley MJ, Kimura T, Mayers DL, Robinson P, Mellors JW, Coffin JM, Palmer SE. Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer design. Journal of Virological Methods. 2010 March; 164(1-2):122-6.

Bridges JFP, Searle SC, Selck FW, Martinson NA. Engaging families in the choice of social marketing strategies for male circumcision services in Johannesburg, South Africa. Social Marketing Quarterly. August 2010; 16(3):60-76.

Celum C, Wald A, Lingappa JR, Margaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Stevens W, Campbell MS, Thomas KK, Coombs RW, Morrow R, Whittington WLH, McElrath MJ, Barnes L, Ridzon R, Corey L for the Partners in Prevention HSV/HIV Transmission Study Team. Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HIV-2. New England Journal of Medicine. 2010 February 4; 362(5):427-39.

Clouse K, Montgomery E, Milford C, Watadzaushe C, Nkala B, Fancher H, Lince N, Cheng H, Thompson M, van der Straten A. Establishing a Continuum of Care between HIV Prevention Trails and Public Healthcare System: The MIRA Standard of Care Program. Clinical Trials. 2010; 7(3):256–264.

Cooper DA, Heera J, Goodrich J, Tawadrous M, Saag M, Dejesus E, Clumeck N, Walmsley S, Ting N, Coakley E, Reeves JD, Reyes-Teran G, Westby M, Van Der Rest E, Ive P, Mohapi L, Mingrone H, Horban A, Hackman F, Sullivan J, Mayer H. Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection. Journal of Infectious Diseases. 2010 March 15; 201(6):803-13.

Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, Giddy J, Wood R, Prozesky H, Mohapi L, Graber C, Egger M, Boulle A, Myer L. International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS. 2010 September 10; 24(14):2263-70.

de Bruyn G. Cofactors that may influence vaccine responses. Current Opinion in HIV & AIDS. 2010 September 5; (5):404-8.

de Bruyn G, Martinson NA, Gray GE. Male circumcision for HIV prevention: developments from sub-Saharan Africa. Expert Review of Anti-Infective Therapy. 2010 January; 8(1):23-31.

Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C; Partners in Prevention HSV/HIV Transmission Study Team. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. The Lancet. 2010 Jun 12; 375(9731):2092-8.

El-Khatib Z, Ekstrom AM, Ledwaba J, Mohapi L, Laher F, Karstaedt A, Charalambous S, Petzold M, Katzenstein D, Morris L. Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa. AIDS. 2010 July 17; 24(11):1679-87.

Essack Z, Slack C, Koen J, Gray G. HIV prevention responsibilities in HIV vaccine trials: Complexities facing South African researchers. South African Medical Journal. 2010 January; 100(1):45-8.

Gray GE. Adolescent HIV—Cause for Concern in Southern Africa. PLoS Medicine. 2010 February; 7(2): e1000227.

Gray G, Buchbinder S, Duerr A. Overview of STEP and Phambili trial results: two phase llb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine. Current Opinion in HIV & AIDS. 2010 September; 5(5):357-61.

Hanrahan CF, Golub JE, Mohapi L, Tshabangu N, Modisenyane T, Chaisson RE, Gray GE, McIntyre JA, Martinson NA. Body mass index and risk of tuberculosis and death. AIDS. 2010 June 19; 24(10):1501-8.

Heffron R, Were E, Celum C, Mugo N, Ngure K, Kiarie J, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team. A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships. Sexually Transmitted Diseases. 2010 October; 37(10):621-8.

Kaida A, Laher F, Strathdee SA, Money D, Janssen PA, Hogg RS, Gray G. Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services. PLoS One. 2010 November 5; 5(11):e13868.

Katz IT, Ware NC, Gray G, Haberer JE, Mellins CA, Bangsberg DR. Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sexual Health. 2010 September; 7(3):279-86.

Laher F, Ashford G, Cescon A, Cullen C, Lazarus E, Puren A, Visser L. Held to ransom: CMV treatment in South Africa. South African Journal of HIV Medicine. 2010 April; 31-34.

Laher F, Miller S, Spencer D. Addressing fears of pregnancy in HIV-infected women on highly active ART. Medical Chronicle. 2010 March; 71.

Laher F, Miller S, Spencer D. Diagnosis and treatment of cytomegalovirus in SA Aids patients. Medical Chronicle. 2010 September; 71. [Article not available online].

Laher F, Todd CS, Stibich MA, Phofa R, Behane X, Mohapi L, Martinson N, Gray G. Role of menstruation in contraceptive choice among hiv-infected women in Soweto, South Africa. Contraception. 2010 June; 81(6):547-51.

Lazarus R, Struthers H, and Violari A. Starting HIV-positive Babies on Antiretroviral Treatment: Perspectives of Mothers in Soweto, South Africa. Journal of Pediatric Health Care. 2010 May-June;24(3):176-83.

Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, Mugo N, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GL, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Magaret AS, Wang RS, Kidoguchi L, Barnes L, Ridzon R, Corey L, Celum C, Partners in Prevention HSV/HIV Transmission Study Team. Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. The Lancet. 2010 March 6; 375(9717):824-33.

Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, Stevens WS, Donnell D, Campbell MS, Farquhar C, Essex M, Mullins JI, Coombs RW, Rees H, Corey L, Wald A; Partners in Prevention HSV/HIV Transmission Study Team. Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One. 2010 September 13;5(9):e12598.

MacCarthy S, Laher F, Nduna M, Farlane L, Kaida A. Responding to her question: a review of the influence of pregnancy on HIV disease progression in the context of expanded access to HAART in Sub-Saharan Africa. AIDS and Behavior. 2009 June; 13(1):66-71.

Madhi SA, Adrian P, Cotton MF, McIntyre JA, Jean- Philippe P, Meadows S, Nachman S, Kayhty H, Klugman K, Violari A. Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. Journal of Infectious Diseases. 2010 Aug 15; 202(3):355-61.

Maenetje P, Riou C, Casazza JP, Ambrozak D, Hill B, Gray G, Koup RA, de Bruyn G, Gray CM. A Steady State of CD4+ T Cell Memory Maturation and Activation Is Established during Primary Subtype C HIV-1 Infection. Journal of Immunology. 2010 May 1; 184(9):4926-35.

Mavedzenge SN, Pol BV, Cheng H, Montgomery ET, Blanchard K, de Bruyn G, Ramjee G, Straten A. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sexually Transmitted Diseases. 2010 July; 37(7):460-6.

Miller L, Folayan M, Allman D, Nkala B, Kasirye LM, Mingote LR, Calazans G, Mburu R, Ntombela F, Ditmore M. How ethical is your clinical trial? The International Journal of Clinical Practice. 2010 August; 64(9):1179-1182.

Palumbo P, Lindsey JC, Hughes MD, Cotton MF, Bobat R, Meyers T, Bwakura-Dangarembizi M, Chi BH, Musoke P, Kamthunzi P, Schimana W, Purdue L, Eshleman SH, Abrams EJ, Millar L, Petzold E, Mofenson LM, Jean-Philippe P, Violari A. Antiretroviral treatment for children with peripartum nevirapine exposure. New England Journal of Medicine. 2010 October 14; 363(16):1510-20.

Rudy BJ, Kapogiannis BG, Lally MA, Gray GE, Bekker LG, Krogstad P, McGowan I. Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials. Journal of Acquired Immune Deficiency Syndromes. 2010 July 1; 54(1):S31-42.

Sanne I, Orrell C, Fox MP, Conradie F, Ive P, Zeinecker J, Cornell M, Heiberg C, Ingram C, Panchia R, Rassool M, Gonin R, Stevens W, Truter H, Dehlinger M, van der Horst C, McIntyre J, Wood R for the Cipra SA Study Team. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomized non-interiority trial. The Lancet. 2010 July 3; 376(9734):33-40.

Schramm DB, Anthony F, Mathebula B, Sherman G, Coovadia A, Gray GE, Kuhn L, Tiemessen CT. Effect of Maternal HIV-1 Status and Antiretroviral Drugs on Haematological Profiles of South African Infants in Early Life. Open AIDS Journal. 2010 August 12; 4:156-65.

Shah M, Martinson NA, Chaisson RE, Martin DJ, Variava E, Dorman SE. Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis. Journal of Clinical Microbiology. 2010 August; 48(8):2972-4.

TEmAA ANRS 12109 Study Group, Arrivé E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Avit D, Kruy LS, McIntyre J, Say L, Gray G, Ekouévi DK, Dabis F. Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance. AIDS. 2010 October 23; 24(16):2481-8.

Tiemessen CT, Shalekoff S, Meddows-Taylor S, Schramm DB, Papathanasopoulos MA, Gray GE, Sherman GG, Coovadia AH, Kuhn L. Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection. Journal of Infectious Diseases. 2010 November 1; 202(9):1444-53.

Uhler LM, Kumarasamy N, Mayer KH, Saxena A, Losina E, Muniyandi M, Stoler AW, Lu Z, Walensky RP, Flanigan TP, Bender MA, Freedberg KA, and Swaminathan S for the CEPAC International investigators. Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India. PLoS One. 2010 September 16; 5(9).

Van der Straten, Cheng H, Chidanyika A, de Bruyn G, Padian N: the MIRA team. Vaginal practices and associations with barrier methods and gel use among Sub-Saharan African women enrolled in an HIV prevention trial. AIDS and Behavior. 2010 June; 14(3):590-9.

Venkatesh KK, de Bruyn G, Lurie MN, Lentle K, Tshabangu N, Moshabela M, Martinson N. Patient referral from nurses to doctors in a nurse-led HIV primary care clinic in South Africa: implications for training and support. AIDS Care. 2010 Nov; 22(11):1332-9.

Venkatesh KK, de Bruyn G, Lurie MN, Mohapi L, Pronyk P, Moshabela M, Maringa E, Gray GE, Triche EW, Martinson NA. Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics. AIDS. 2010 November 13 ;24(17):2687-96.

Venkatesh K, Lurie MN, Triche EW, De Bruyn G, Harwell JI, McGarvey ST, Gray GE. Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics. Tropical Medicine & International Health. 2010 November; 15(11):1364-74.